查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
多重检测市场：现状分析与预测（2022-2028 年）
市场调查报告书
商品编码
1260699

多重检测市场：现状分析与预测（2022-2028 年）

Multiplex Assay Market: Current Analysis and Forecast (2022-2028)
出版日期: | 出版商: UnivDatos Market Insights Pvt Ltd | 英文 150 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

从 2022 年到 2028 年，多重检测市场的复合年增长率预计将达到 7% 左右。 多重测定是一种生物测定，可以同时测量一个样品中的多种分析物（蛋白质、核酸、代谢物等）。 这种技术在生物技术和生物医学研究中越来越受欢迎，因为它可以同时提供有关多个生物分子的综合信息。 分子和伴随诊断领域不断扩大的研发需求推动了对多重检测的需求不断增长，推动了全球主要行业参与者采用有机增长战略。可以考虑。 例如，针对COVID-19疫情，Thermo Fisher Scientific推出了多重实时PCR诊断试剂盒（TaqPath COVID-19 developed the Multiplex Diagnostic Solution。

根据技术，多重检测市场细分为多重实时 PCR、流式细胞术等。 多重实时 PCR 部分占有很大的市场份额，预计在预测期内将快速增长。 PCR 技术广泛用于各种最终用途。 此外，PCR技术在COVID-19检测中的广泛应用，也为这项技术带来了可观的收入。

根据应用，市场分为临床诊断和研发。 研发部门在预测期内获得了相当大的市场份额。 它在药物发现过程中的使用正在增加。 这些测试已用于评估临床前和临床阶段的药物反应生物标誌物、免疫治疗功效和毒性。

为了更好地了解多重检测的市场采用情况，北美（美国、加拿大、北美其他地区）、欧洲（德国、法国、意大利、西班牙、英国、欧洲其他地区）、亚太地区（中国、日本） )、印度、澳大利亚、亚太其他地区)，以及该地区其他国家/地区的市场占有率。 由于存在各种研究计划和积极的研发活动以创造新药、诊断学和治疗学，北美形成了多重分析行业的主要市场。 增加政府对新生物标誌物发现的资助以及癌症和中风等慢性病发病率的增加预计将推动该地区的增长。 此外，该地区主要参与者的存在也可能有助于推动这一增长。

Luminex Corporation、Thermo Fisher Scientific Inc.、Bio-Rad Laboratories, Inc.、QIAGEN N.V.、Becton、Dickinson and Company、Merck KGaA、Seegene Inc、Perkin Elmer Inc、Abcam PLC、Agilent Technologies Inc. 主要参与者谁是 这些公司进行了多项併购和合作。

内容

1 市场介绍

  • 市场定义
  • 主要目的
  • 利益相关者
  • 限制

第 2 章研究方法或假设

  • 研究过程
  • 调查方法
  • 受访者简介

第三章市场总结

第 4 章执行摘要

第 5 章 COVID-19 对多重检测市场的影响

第 6 章多重检测市场收入，2020-2028F

第 7 章市场洞察：按产品分类

  • 试剂和耗材
  • 仪器和配件
  • 软件和服务

第 8 章市场洞察：按类型

  • 基于蛋白质的多重分析
  • 基于核酸的多重分析
  • 其他

第 9 章市场洞察：按技术

  • 多重实时 PCR
  • 流式细胞术
  • 其他

第 10 章市场洞察：按应用

  • 临床诊断
  • 研究与开发

第 11 章市场洞察：最终用户

  • 製药和生物技术公司
  • 医院和诊断实验室
  • 研究和学术机构
  • 其他

第 12 章市场洞察：按地区

  • 北美
    • 美国
    • 加拿大
    • 其他北美地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 意大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳大利亚
    • 其他亚太地区
  • 世界其他地方

第 13 章多重分析市场动态

  • 市场驱动力
  • 市场挑战
  • 影响分析

第 14 章多重分析市场机会

第 15 章多重分析市场趋势

第16章需求侧与供给侧分析

  • 需求方分析
  • 供应方分析

第 17 章价值链分析

第 18 章战略洞察

第 19 章衝突场景

  • 竞争格局
    • 波特的五力分析

第20章公司简介

  • Qiagen NV
  • New England Biolabs
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • BGI Genomics Co Ltd
  • Oxford Nanopore Technologies PLC
  • PerkinElmer, Inc.
  • Becton Dickinson and Co
  • Bayer AG
  • Agilent Technologies Inc

第21章 免责事项

简介目录
Product Code: UMHE211736

The Multiplex Assay Market is expected to register a CAGR of approx. 7% over the period of 2022-2028. Multiplex assay is a type of biological assay that allows simultaneous measurement of multiple analytes (such as proteins, nucleic acids, or metabolites) in a single sample. This technique has gained increasing popularity in the field of biotechnology and biomedical research due to its ability to provide comprehensive information on multiple biomolecules at once. The growing demand for multiplex assay can be attributed to the expanding need for research and development in the fields of molecular diagnostics and companion diagnostics which boosts the adoption of organic growth strategies among key industry players around the globe. For instance, in response to the COVID-19 outbreak, Thermo Fisher Scientific developed a multiplex real-time PCR diagnostic kit (TaqPath COVID-19 Multiplex Diagnostic Solution) to facilitate public and clinical health laboratories to rapidly diagnose SARS-CoV-2 infection.

Based on the technology, the multiplex assay market is segmented into multiplex real-time PCR, flow cytometry, and others. The multiplex real-time PCR segment accounted for a significant market share, and it is estimated that it will grow rapidly during the projected timeframe. PCR technology is widely used in a variety of end-use applications. Furthermore, the widespread use of PCR technologies for COVID-19 detection has resulted in significant revenue generation by this technology.

Based on the application, the market is fragmented into clinical diagnostics and research & development. The research & development segment grabbed a considerable market share during the forecast period. Multiplex assays are becoming more and more used in the drug discovery process. These tests are employed in preclinical and clinical phases to assess drug response biomarkers, immunotherapy efficacy, and toxicity.

For a better understanding of the market adoption of multiplex assay, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, U.K., and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the multiplex assay industry owing to the presence of various research programs in the region, as well as the expansion of R&D efforts for the creation of new medications and diagnostic and therapeutic approaches. The rise in government financing for the discovery of new biomarkers and the increased frequency of chronic diseases like cancer and stroke are expected to fuel the region's growth. Furthermore, the rise is probably going to be fueled by the presence of important players in the area.

Some of the major players operating in Luminex Corporation, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN N.V., Becton, Dickinson and Company, Merck KGaA, Seegene Inc., Perkin Elmer Inc., Abcam PLC, Agilent Technologies Inc. among others. Several M&A's along with partnerships have been undertaken by these players.

TABLE OF CONTENTS

1MARKET INTRODUCTION

  • 1.1. Market Definitions
  • 1.2. Main Objective
  • 1.3. Stakeholders
  • 1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

  • 2.1. Research Process of the Multiplex Assay Market
  • 2.2. Research Methodology of the Multiplex Assay Market
  • 2.4. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE MULTIPLEX ASSAY MARKET

6 MULTIPLEX ASSAY MARKET REVENUE, 2020-2028F

7 MARKET INSIGHTS BY PRODUCT

  • 7.1. Reagents & Consumables
  • 7.2. Instruments & Accessories
  • 7.3. Software & Services

8 MARKET INSIGHTS BY TYPE

  • 8.1. Protein-Based Multiplex Assay
  • 8.2. Nucleic Acid-Based Multiplex Assay
  • 8.3. Others

9 MARKET INSIGHTS BY TECHNOLOGY

  • 9.1. Multiplex Real-Time PCR
  • 9.2. Flow Cytometry
  • 9.3. Others

10 MARKET INSIGHTS BY APPLICATION

  • 10.1 Clinical Diagnostics
  • 10.2 Research & Development

11 MARKET INSIGHTS BY END-USER

  • 11.1. Pharmaceutical & Biotechnology Companies
  • 11.2. Hospitals & Diagnostic laboratories
  • 11.3. Research & Academic Institutes
  • 11.4. Others

12 MARKET INSIGHTS BY REGION

  • 12.1 NORTH AMERICA
    • 12.1.1 United States
    • 12.1.2 Canada
    • 12.1.3 Rest of North America
  • 12.2 EUROPE
    • 12.2.1 Germany
    • 12.2.2 France
    • 12.2.3 United Kingdom
    • 12.2.4 Spain
    • 12.2.5 Italy
    • 12.2.6 Rest of Europe
  • 12.3 ASIA PACIFIC
    • 12.3.1 China
    • 12.3.2 Japan
    • 12.3.3 India
    • 12.3.4 Australia
    • 12.3.5 Rest of Asia Pacific
  • 12.4 REST OF THE WORLD

13 MULTIPLEX ASSAY MARKET DYNAMICS

  • 13.1 Market Drivers
  • 13.2 Market Challenges
  • 13.3 Impact Analysis

14 MULTIPLEX ASSAY MARKET OPPORTUNITIES

15 MULTIPLEX ASSAY MARKET TRENDS

16 DEMAND AND SUPPLY SIDE ANALYSIS

  • 16.1 Demand Side Analysis
  • 16.2 Supply Side Analysis

17 VALUE CHAIN ANALYSIS

18 STRATEGIC INSIGHTS

19 COMPETITIVE SCENARIO

  • 19.1. Competitive Landscape
    • 19.1.1 Porter's Five forces analysis

20 COMPANY PROFILED

  • 20.1. Qiagen NV
  • 20.2. New England Biolabs
  • 20.3. Illumina, Inc.
  • 20.4. Bio-Rad Laboratories, Inc.
  • 20.5. BGI Genomics Co Ltd
  • 20.6. Oxford Nanopore Technologies PLC
  • 20.7. PerkinElmer, Inc.
  • 20.8. Becton Dickinson and Co
  • 20.9. Bayer AG
  • 20.10. Agilent Technologies Inc

21 DISCLAIMER